Exploring the regulatory challenges and scientific breakthroughs in human embryonic stem cell research in the United States, with proposals for harmonizing policies.
Explore conditional approval pathways in regenerative medicine regulation - the regulatory fast lanes reshaping how breakthrough therapies reach patients worldwide.